These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 21958773)

  • 1. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
    Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
    Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.
    Kulik A; Le May MR; Voisine P; Tardif JC; Delarochelliere R; Naidoo S; Wells GA; Mesana TG; Ruel M
    Circulation; 2010 Dec; 122(25):2680-7. PubMed ID: 21135365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
    Une D; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709).
    Kulik A; Abreu AM; Boronat V; Ruel M
    Contemp Clin Trials; 2017 Aug; 59():98-104. PubMed ID: 28611006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial.
    Jerzewski K; Ruel M; Voisine P; Le May MR; Kulik A
    J Cardiothorac Surg; 2013 Jul; 8():172. PubMed ID: 23842141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
    Zhu J; Zhu Y; Zhang M; Xue Q; Hu J; Liu H; Wang R; Wang X; Zhao Q
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1030-1039.e4. PubMed ID: 32359899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
    Taggart DP; Ben Gal Y; Lees B; Patel N; Webb C; Rehman SM; Desouza A; Yadav R; De Robertis F; Dalby M; Banning A; Channon KM; Di Mario C; Orion E
    Ann Thorac Surg; 2015 Jun; 99(6):2039-45. PubMed ID: 25886810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins.
    Ezhov MV; Il'ina LN; Safarova MS; Afanasieva OI; Adamova IY; Atanesyan RV; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2013 Jan; 14(1):101-5. PubMed ID: 23357150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clopidogrel use post coronary artery bypass surgery on graft patency.
    Ebrahimi R; Bakaeen FG; Uberoi A; Ardehali A; Baltz JH; Hattler B; Almassi GH; Wagner TH; Collins JF; Grover FL; Shroyer AL
    Ann Thorac Surg; 2014 Jan; 97(1):15-21. PubMed ID: 24206971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
    Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
    Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
    J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipid levels and high-intensity statins on vein graft patency after CABG: Midterm results of the ACTIVE trial.
    Kulik A; Abreu AM; Boronat V; Ruel M
    J Card Surg; 2020 Dec; 35(12):3286-3293. PubMed ID: 33025656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
    Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
    JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial.
    Goldman S; Sethi GK; Holman W; Thai H; McFalls E; Ward HB; Kelly RF; Rhenman B; Tobler GH; Bakaeen FG; Huh J; Soltero E; Moursi M; Haime M; Crittenden M; Kasirajan V; Ratliff M; Pett S; Irimpen A; Gunnar W; Thomas D; Fremes S; Moritz T; Reda D; Harrison L; Wagner TH; Wang Y; Planting L; Miller M; Rodriguez Y; Juneman E; Morrison D; Pierce MK; Kreamer S; Shih MC; Lee K
    JAMA; 2011 Jan; 305(2):167-74. PubMed ID: 21224458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial.
    Kulik A; Abreu AM; Boronat V; Ruel M
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):151-161.e1. PubMed ID: 30122341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively.
    Schoettler J; Jussli-Melchers J; Grothusen C; Stracke L; Schoeneich F; Stohn S; Hoffmann G; Cremer J
    Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):396-400. PubMed ID: 21724659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.